Show simple item record

Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1 : a multicentre, single-blind, randomised trial

dc.contributor.authorOkkersen, Kees
dc.contributor.authorJimenez-Moreno, Cecilia
dc.contributor.authorWenninger, Stephan
dc.contributor.authorDaidj, Ferroudja
dc.contributor.authorGlennon, Jeffrey
dc.contributor.authorCumming, Sarah
dc.contributor.authorLittleford, Roberta
dc.contributor.authorMonckton, Darren G.
dc.contributor.authorLochmüller, Hanns
dc.contributor.authorCatt, Michael
dc.contributor.authorFaber, Catharina G.
dc.contributor.authorHapca, Adrian
dc.contributor.authorDonnan, Peter T.
dc.contributor.authorGorman, Gráinne
dc.contributor.authorBassez, Guillaume
dc.contributor.authorSchoser, Benedikt
dc.contributor.authorKnoop, Hans
dc.contributor.authorTreweek, Shaun
dc.contributor.authorvan Engelen, Baziel G.M.
dc.contributor.authorOPTIMISTIC Consortium
dc.date.accessioned2018-12-19T00:05:36Z
dc.date.available2018-12-19T00:05:36Z
dc.date.issued2018-08-01
dc.identifier119905321
dc.identifier1fbf3b7e-8c70-43e4-9c3e-62e98e9abb58
dc.identifier85048813421
dc.identifier.citationOkkersen , K , Jimenez-Moreno , C , Wenninger , S , Daidj , F , Glennon , J , Cumming , S , Littleford , R , Monckton , D G , Lochmüller , H , Catt , M , Faber , C G , Hapca , A , Donnan , P T , Gorman , G , Bassez , G , Schoser , B , Knoop , H , Treweek , S , van Engelen , B G M & OPTIMISTIC Consortium 2018 , ' Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1 : a multicentre, single-blind, randomised trial ' , The Lancet neurology , vol. 17 , no. 8 , pp. 671-680 . https://doi.org/10.1016/S1474-4422(18)30203-5en
dc.identifier.issn1474-4422
dc.identifier.urihttp://hdl.handle.net/2164/11677
dc.descriptionThis study was funded by the European Union Seventh Framework Program, under grant agreement number 305697 (the Observational Prolonged Trial In Myotonic dystrophy type 1 to Improve Quality of Life Standards, a Target Identification Collaboration [OPTIMISTIC] project). We thank Marie Kierkegaard (Karolinska University Hospital, Karolinska Institutet, Department of Physical Therapy, Sweden) and Don MacKenzie (Marigold Foundation, Calgary, AB, Canada) as members of the external advisory board for their continued monitoring and recommendations for improvement of our study. The Health Services Research Unit (University of Aberdeen, Aberdeen, UK) receives core funding from the Chief Scientist Office of the Scottish Government Health Directorates. We acknowledge the contribution to this study made by the Tayside Clinical Trials Unit, University of Dundee (Dundee, UK).en
dc.format.extent10
dc.format.extent645901
dc.language.isoeng
dc.relation.ispartofThe Lancet neurologyen
dc.subjectRC0321 Neuroscience. Biological psychiatry. Neuropsychiatryen
dc.subjectEuropean Commissionen
dc.subject305697en
dc.subjectChief Scientist Office (CSO)en
dc.subjectSupplementary Dataen
dc.subject.lccRC0321en
dc.titleCognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1 : a multicentre, single-blind, randomised trialen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Health Services Research Uniten
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.identifier.doi10.1016/S1474-4422(18)30203-5
dc.date.embargoedUntil2018-12-19


Files in this item

Thumbnail
Name:
Lancet_Neurology_Okkersen_4th_ ...
Size:
630.7Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record